Specific aims of the current study were to study the effect of diabetic and CKD milieu on a) GLO1 gene expression; b) GLO1 protein level; and c) GLO1 activity in vivo in diabetic vs. non-diabetic subjects with corresponding CKD stages. Here, GLO1 is linked to chronic kidney disease.